These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 34381648)
1. Comparison of Testosterone Levels in Patients With and Without Type 2 Diabetes. Kumari N; Khan A; Shaikh U; Lobes K; Kumar D; Suman F; Bhutto NS; Anees F; Shahid S; Rizwan A Cureus; 2021 Jul; 13(7):e16288. PubMed ID: 34381648 [TBL] [Abstract][Full Text] [Related]
2. Frequency of Hypogonadism and Erectile Dysfunction in Type-II Diabetic Patients. Mushtaq S; Khan K; Abid S; Umer A; Raza T Cureus; 2018 May; 10(5):e2654. PubMed ID: 30034976 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of Hypogonadism among diabetic and non-diabetic men in Jordan. Al Hayek AA; Khawaja NM; Khader YS; Jaffal SK; Ajlouni KM J Diabetes Complications; 2014; 28(2):135-40. PubMed ID: 24388552 [TBL] [Abstract][Full Text] [Related]
4. Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease. Raza MT; Sharif S; Khan ZA; Naz S; Mushtaq S; Umer A Cureus; 2019 Dec; 11(12):e6500. PubMed ID: 32025421 [TBL] [Abstract][Full Text] [Related]
5. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus. Ogbera OA; Sonny C; Olufemi F; Wale A J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405 [TBL] [Abstract][Full Text] [Related]
6. Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover. Colleluori G; Aguirre L; Dorin R; Robbins D; Blevins D; Barnouin Y; Chen R; Qualls C; Villareal DT; Armamento-Villareal R Bone; 2017 Jun; 99():14-19. PubMed ID: 28323146 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of low testosterone levels in men with type 2 diabetes mellitus; a case-control study in a district hospital in Ghana. Serwaa D; Bello FA; Osungbade KO; Nkansah C; Osei-Boakye F; Appiah SK; Antwi MH; Danquah M; Buckman TA; Owusu E PLOS Glob Public Health; 2021; 1(12):e0000052. PubMed ID: 36962255 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease. Dhindsa S; Reddy A; Karam JS; Bilkis S; Chaurasia A; Mehta A; Raja KP; Batra M; Dandona P Eur J Endocrinol; 2015 Sep; 173(3):359-66. PubMed ID: 26101371 [TBL] [Abstract][Full Text] [Related]
9. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Haider KS; Haider A; Saad F; Doros G; Hanefeld M; Dhindsa S; Dandona P; Traish A Diabetes Obes Metab; 2020 Nov; 22(11):2055-2068. PubMed ID: 32558149 [TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical correlates of male hypogonadism in type 2 diabetes. Herrero A; Marcos M; Galindo P; Miralles JM; Corrales JJ Andrology; 2018 Jan; 6(1):58-63. PubMed ID: 29145714 [TBL] [Abstract][Full Text] [Related]
11. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Corona G; Mannucci E; Petrone L; Ricca V; Balercia G; Mansani R; Chiarini V; Giommi R; Forti G; Maggi M Int J Impot Res; 2006; 18(2):190-7. PubMed ID: 16136189 [TBL] [Abstract][Full Text] [Related]
12. Association Between Long-Term Use of Non-steroidal Anti-inflammatory Drugs and Hyperkalemia in Diabetic Patients. Sahil F; Kumar J; Raiz G; Bhutto NS; Tahir H; Anjum Z; Naz S; Rizwan A; Jahangir M; Muhammad Shehzad S Cureus; 2021 Jun; 13(6):e15648. PubMed ID: 34306858 [TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients. Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788 [TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886 [TBL] [Abstract][Full Text] [Related]
15. Patients with testosterone deficiency syndrome and type 2 diabetes. Corona G; Maggi M Arch Esp Urol; 2013 Sep; 66(7):711-22. PubMed ID: 24047631 [TBL] [Abstract][Full Text] [Related]
16. Association of erectile dysfunction and type II diabetes mellitus at a tertiary care centre of south India. Nutalapati S; Ghagane SC; Nerli RB; Jali MV; Dixit NS Diabetes Metab Syndr; 2020; 14(4):649-653. PubMed ID: 32438327 [TBL] [Abstract][Full Text] [Related]
17. Association of Low Magnesium Level With Duration and Severity of Type 2 Diabetes. Paladiya R; Pitliya A; Choudhry AA; Kumar D; Ismail S; Abbas M; Naz S; Kumar B; Jamil A; Fatima A Cureus; 2021 May; 13(5):e15279. PubMed ID: 34194881 [TBL] [Abstract][Full Text] [Related]
18. Frequency and Correlates of Hypogonadism in Adult Males with Type 2 Diabetes Mellitus. Gangwar SK; Verma SK; Modi S Indian J Endocrinol Metab; 2021; 25(4):320-325. PubMed ID: 35136739 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Kapoor D; Aldred H; Clark S; Channer KS; Jones TH Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of erectile dysfunction among Saudi type 2 diabetic patients. Hassan A; Aburisheh K; Sheikh TJ; Meo SA; Ahmed NA; Al Sharqawi AH Eur Rev Med Pharmacol Sci; 2014; 18(7):1048-57. PubMed ID: 24763886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]